Correlation Between Vigil Neuroscience and Eledon Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Vigil Neuroscience and Eledon Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vigil Neuroscience and Eledon Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vigil Neuroscience and Eledon Pharmaceuticals, you can compare the effects of market volatilities on Vigil Neuroscience and Eledon Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vigil Neuroscience with a short position of Eledon Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vigil Neuroscience and Eledon Pharmaceuticals.
Diversification Opportunities for Vigil Neuroscience and Eledon Pharmaceuticals
0.18 | Correlation Coefficient |
Average diversification
The 3 months correlation between Vigil and Eledon is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Vigil Neuroscience and Eledon Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eledon Pharmaceuticals and Vigil Neuroscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vigil Neuroscience are associated (or correlated) with Eledon Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eledon Pharmaceuticals has no effect on the direction of Vigil Neuroscience i.e., Vigil Neuroscience and Eledon Pharmaceuticals go up and down completely randomly.
Pair Corralation between Vigil Neuroscience and Eledon Pharmaceuticals
Given the investment horizon of 90 days Vigil Neuroscience is expected to under-perform the Eledon Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Vigil Neuroscience is 1.85 times less risky than Eledon Pharmaceuticals. The stock trades about -0.32 of its potential returns per unit of risk. The Eledon Pharmaceuticals is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 337.00 in Eledon Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of 64.00 from holding Eledon Pharmaceuticals or generate 18.99% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vigil Neuroscience vs. Eledon Pharmaceuticals
Performance |
| Timeline |
| Vigil Neuroscience |
| Eledon Pharmaceuticals |
Vigil Neuroscience and Eledon Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vigil Neuroscience and Eledon Pharmaceuticals
The main advantage of trading using opposite Vigil Neuroscience and Eledon Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vigil Neuroscience position performs unexpectedly, Eledon Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eledon Pharmaceuticals will offset losses from the drop in Eledon Pharmaceuticals' long position.| Vigil Neuroscience vs. Molecular Partners AG | Vigil Neuroscience vs. Pmv Pharmaceuticals | Vigil Neuroscience vs. Monte Rosa Therapeutics | Vigil Neuroscience vs. Entrada Therapeutics |
| Eledon Pharmaceuticals vs. Inozyme Pharma | Eledon Pharmaceuticals vs. Day One Biopharmaceuticals | Eledon Pharmaceuticals vs. Terns Pharmaceuticals | Eledon Pharmaceuticals vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |